Hu Y - Search Results

1

(+)/(-)-Gerbeloid A, a pair of unprecedented coumarin-based polycyclic meroterpenoid enantiomers from Gerbera piloselloides: Structural elucidation, semi-synthesis, and lipid-lowering activity.

Zhao C, Li J, Hu Y, Li L, Yu M, Huang Y, Zhang T, Shang H, Zou Z. Zhao C, et al. Among authors: hu y. Acta Pharm Sin B. 2024 Jun;14(6):2657-2668. doi: 10.1016/j.apsb.2024.03.035. Epub 2024 Mar 30. Acta Pharm Sin B. 2024. PMID: 38828137 Free PMC article.

2

The Synthesis and Biological Evaluation of Aloe-Emodin-Coumarin Hybrids as Potential Antitumor Agents.

Shang H, Hu Y, Li J, Li L, Tian Y, Li X, Wu Q, Zou Z. Shang H, et al. Among authors: hu y. Molecules. 2022 Sep 20;27(19):6153. doi: 10.3390/molecules27196153. Molecules. 2022. PMID: 36234685 Free PMC article.

3

Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease.

Li L, Ma L, Hu Y, Li X, Yu M, Shang H, Zou Z. Li L, et al. Among authors: hu y. Phytochemistry. 2022 Jan;193:112984. doi: 10.1016/j.phytochem.2021.112984. Epub 2021 Oct 12. Phytochemistry. 2022. PMID: 34757253 Free PMC article.

4

Design, synthesis and evaluation of ursodeoxycholic acid-cinnamic acid hybrids as potential anti-inflammatory agents by inhibiting Akt/NF-κB and MAPK signaling pathways.

Li X, Hu Y, He B, Li L, Tian Y, Xiao Y, Shang H, Zou Z. Li X, et al. Among authors: hu y. Eur J Med Chem. 2023 Nov 15;260:115785. doi: 10.1016/j.ejmech.2023.115785. Epub 2023 Aug 31. Eur J Med Chem. 2023. PMID: 37678142

5

Design, synthesis and evaluation of novel UDCA-aminopyrimidine hybrids as ATX inhibitors for the treatment of hepatic and pulmonary fibrosis.

Hu Y, Li L, Tian Y, Xiao Y, Tang J, Zeng S, Zou Z, Shang H. Hu Y, et al. Eur J Med Chem. 2024 Jan 15;264:116029. doi: 10.1016/j.ejmech.2023.116029. Epub 2023 Dec 8. Eur J Med Chem. 2024. PMID: 38091892

6

SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.

Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y. Zhu Y, et al. Among authors: hu y. Signal Transduct Target Ther. 2021 Aug 3;6(1):294. doi: 10.1038/s41392-021-00698-x. Signal Transduct Target Ther. 2021. PMID: 34344868 Free PMC article. No abstract available.

7

In Vitro Selection and Characterization of HIV-1 Variants with Increased Resistance to LP-40, Enfuvirtide-Based Lipopeptide Inhibitor.

Hu Y, Yu W, Geng X, Zhu Y, Chong H, He Y. Hu Y, et al. Int J Mol Sci. 2022 Jun 14;23(12):6638. doi: 10.3390/ijms23126638. Int J Mol Sci. 2022. PMID: 35743078 Free PMC article.

8

Resistance profile and mechanism of severe acute respiratory syndrome coronavirus-2 variants to LCB1 inhibitor targeting the spike receptor-binding motif.

Wu T, Zhu Y, Liu N, Hu Y, Chong H, He Y. Wu T, et al. Among authors: hu y. Front Microbiol. 2022 Oct 11;13:1022006. doi: 10.3389/fmicb.2022.1022006. eCollection 2022. Front Microbiol. 2022. PMID: 36304946 Free PMC article.

9

A forkhead transcription factor contributes to the regulatory differences of pathogenicity in closely related fungal pathogens.

Ke W, Xie Y, Hu Y, Ding H, Fan X, Huang J, Tian X, Zhang B, Xu Y, Liu X, Yang Y, Wang L. Ke W, et al. Among authors: hu y. mLife. 2022 Mar 24;1(1):79-91. doi: 10.1002/mlf2.12011. eCollection 2022 Mar. mLife. 2022. PMID: 38818325 Free PMC article.

10

Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides.

Zhu Y, Hu Y, Liu N, Chong H, He Y. Zhu Y, et al. Among authors: hu y. Antiviral Res. 2022 Dec;208:105445. doi: 10.1016/j.antiviral.2022.105445. Epub 2022 Oct 17. Antiviral Res. 2022. PMID: 36265805 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,856 results

Search Page

Filters